No photo of Suhayl Dhib-Jalbut
Contact Expert

View Scopus Profile

Suhayl Dhib-Jalbut

Rutgers, The State University

 https://orcid.org/0000-0002-4356-5306
    • 6401 Citations
    • 40 h-Index
    1981 …2019
    If you made any changes in Pure, your changes will be visible here soon.

    Fingerprint Dive into the research topics where Suhayl Dhib-Jalbut is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 13 Similar Profiles
    Multiple Sclerosis Medicine & Life Sciences
    Interferons Medicine & Life Sciences
    Measles virus Medicine & Life Sciences
    Subacute Sclerosing Panencephalitis Medicine & Life Sciences
    T-Lymphocytes Medicine & Life Sciences
    Therapeutics Medicine & Life Sciences
    Cytokines Medicine & Life Sciences
    Measles Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 1981 2019

    5 Citations (Scopus)

    Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis

    Ito, K. & Dhib-Jalbut, S., Apr 12 2019, In : Journal of Molecular Medicine. 97, 4, p. 463-472 10 p.

    Rutgers, The State University

    Research output: Contribution to journal › Review article

    Multiple Sclerosis
    Mouth Diseases
    Th2 Cells
    Myeloid Cells
    Blood-Brain Barrier
    14 Citations (Scopus)

    Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood

    Dhib-Jalbut, S. & Ito, K., Oct 31 2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 44, p. E9318-E9327

    Rutgers, The State University

    Research output: Contribution to journal › Article

    Dysbiosis
    Central Nervous System
    Multiple Sclerosis
    Autoimmunity
    Autoimmune Experimental Encephalomyelitis
    4 Citations (Scopus)

    IL-27: a potential biomarker for responders to glatiramer acetate therapy

    Dhib-Jalbut, S. & Ito, K., Mar 15 2017, In : Journal of Neuroimmunology. 304, p. 21-28 8 p.

    Rutgers, The State University

    Research output: Contribution to journal › Article

    Interleukin-27
    Biomarkers
    Therapeutics
    Relapsing-Remitting Multiple Sclerosis
    Glatiramer Acetate
    67 Citations (Scopus)

    Brain health: time matters in multiple sclerosis

    Dhib-Jalbut, S., Jun 30 2016, In : Multiple Sclerosis and Related Disorders. 9, p. S5-S48

    Rutgers, The State University

    Research output: Contribution to journal › Review article

    Multiple Sclerosis
    Health
    Brain
    Therapeutics
    Consensus
    66 Citations (Scopus)

    Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: A randomised, placebo-controlled, phase 2 trial

    Dhib-Jalbut, S., Jan 1 2016, In : The Lancet Neurology. 15, 1, p. 35-46 12 p.

    Rutgers, The State University

    Research output: Contribution to journal › Article

    Relapsing-Remitting Multiple Sclerosis
    Estriol
    Placebos
    Recurrence
    Multiple Sclerosis

    Press/Media

    At the Board: June 2018

    Suhayl Dhib-Jalbut

    6/12/18

    1 item of Media coverage

    Press/Media: Press / Media

    AT THE BOARD: JUNE 2018

    Suhayl Dhib-Jalbut

    6/12/18

    1 item of Media coverage

    Press/Media: Press / Media

    ACTRIMS 2018: Emerging Pathways, New Therapeutic Targets in MS

    Suhayl Dhib-Jalbut

    1/29/18

    1 item of Media coverage

    Press/Media: Press / Media

    Dementia & Neurogenetics Faculty

    Suhayl Dhib-Jalbut

    1/27/18

    1 item of Media coverage

    Press/Media: Press / Media

    Suhayl Dhib-Jalbut, M.D., to present findings in keynote address at ACTRIMS Forum 2018

    Suhayl Dhib-Jalbut

    11/30/17

    1 item of Media coverage

    Press/Media: Press / Media